#PVLA
#$PVLA off-exchange volume ran 0.7x normal on Nov 17, 5-day trend fading.
37.0% of #$PVLA volume traded off-exchange, vs a 40.4% average over the prior 4 sessions.
Big-block activity is cooling: price is being set on the lit market.

Full story at the link.
#darkpool #stocks #stockmarket
Palvella (PVLA) Technical Levels: Support $143.15, Resistance $148.90
PVLA closed at $144.35: support $143.15, resistance $148.90; where the chart, options flow and dark pools stand after the close.
globaltradersacademy.com
November 18, 2026 at 3:45 AM
🔴 #PVLA: Martini Jeffrey S, Chief Scientific Officer
SOLD: 1,449 shares @ $164.85
Total: $239K
Trade date Nov 10, 2026
📈 History & trend → https://www.formdelta.com/ticker/PVLA

#InsiderTrading #PVLA #StockMarket
FormDelta: Insider Trading Alerts
Martini Jeffrey S just sold $239K in PVLA. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
November 12, 2026 at 11:59 PM
#$PVLA: Off-exchange shares (share of volume): Nov 12 110,639 (39.1%).
#$PVLA options tape: calls $157K, puts $32K (total $189K) (83% calls).

Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.

Full story at the link.
#darkpool #stocks #stockmarket
Palvella (PVLA) Technical Levels: Options Flow, Dark Pools Line Up Above $145
PVLA at $153.18: support $145.19, resistance $179.95; the chart, options flow and dark pools line up bullish.
globaltradersacademy.com
November 13, 2026 at 12:25 PM
#$ZYME: $200M buyback (~$140M by 2028) to lift returns while funding R&D & deals. #$RPID: Merck KGaA buyout at $0.75/share cash (close Dec 2026); automates pharma microbe testing. #$PVLA: Leerink Outperform $228 PT—QTORIN path solid, FDA Feb 2027, platform ready. notreload.xyz/wall-street-...
November 16, 2026 at 2:46 PM
🚨 $PVLA
JEFFREY MARTINI, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $8,704,000.00, on 11/10/2026.
SEC Filing: PVLA
Click to view the official SEC document.
www.sec.gov
November 10, 2026 at 9:42 PM
#$PVLA: PVLA Technical Levels: Chart, Options Flow and Dark Pools Diverge at $174.

Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.

Read the full article for the full details.
#darkpool #stocks #fintwit
PVLA Technical Levels: Chart, Options Flow and Dark Pools Diverge at $174
PVLA at $174.08: support $143.02, resistance $179.32; the chart, options flow and dark pools point in different directions.
globaltradersacademy.com
November 10, 2026 at 1:09 AM
Stage Analysis Screener – Stage 2 Breakouts & Continuation Breakouts

FISV, PCOR, AHR, IBN, STE, SNY, RYAN, YUMC, HTHT, AMX, TM, COLD, SHLS, LION, PVLA, PAC, PHG, SUZ, VCEL, CWT, HLF, ESRT
November 7, 2026 at 12:28 AM
Palvella Therapeutics $PVLA reported Q3 2026 EPS of -$1.70, beating the -$1.72 estimate by 1.2%.

https://fundspec.ai/s/PVLA/earnings
Watchlists that sync across every device you own.
November 5, 2026 at 12:38 PM
🚨 $PVLA
On November 5, 2026, the Company will hold its earnings call and use a slide presentation in conjunction with the earnings call.
SEC Filing: PVLA
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 12:30 PM
$ON-1 $KD-1 $CPRI-1 $ASX-1 $PVLA-1 $PFGC-1 $PPL-1 $SPXU-1 $APA-1 $STUB-1 $AVGO-1 $XYZ-1 $ABBV-1 $XYLD-1 $ALM-1 $RC-1 $ENB-1 $MDT-1 $DVN-1 $HL-1 $AIRR-1 $EROC-1 $DIS-1 $EQNR-1

Daily Wrap - Final Message: Daily Wrap up for 2026-11-06 - 4557 events.

#burst_trades #HFT #trading ...
November 6, 2026 at 9:24 PM
So pleased to see the continued progress at Palvella, #$PVLA.

ir.palvellatx.com/news-release...
ir.palvellatx.com
November 3, 2026 at 1:09 PM
#BiotechHangout: Chris Garabedian, Sam Fazeli, Brian Skorney, Graig Suvannavejh, Yaron Werber on macro: pharma earnings, #$ALNY, Anthropic & Mithril, IPOs, regulatory: FDA rare disease pathway meeting, #$PVLA, Plowshare, data & conferences: #$ABOS, #KidneyWeek, #$BIIB, #ESMO2026: x.com/i/spaces/1pe...
October 30, 2026 at 1:55 PM
Palvella Therapeutics ($PVLA) – 13G holder adds

• Holder: Jennison Associates
• Stake: 6.7% → 7.7% (about $146M)
• Shares: 960,619 → 1,101,652
• Filed: Oct 28 · Schedule 13G/A

📊 Track ownership filings at www.elixstocks.com

Educational purposes only. Not investment advice.

#Investing #Stocks
Jennison Associates LLC: 7.7% of Palvella Therapeutics ($PVLA)
Schedule 13G/A filed Oct 28. Who filed, the stake, and how it changed.
elixstocks.com
October 28, 2026 at 9:48 PM
🚨 JUST IN: $PVLA
FDA accepts Palvella's QTORIN rapamycin NDA with Priority Review; PDUFA date Feb 28, 2027

#SEC #stocks #investing #PVLA #Regulatory
🔗 secwatch.observer
October 28, 2026 at 11:37 AM
🟢 #$PVLA — Regulatory Designation
Priority Review Granted - QTORIN Rapamycin NDA
FDA granted Priority Review to the QTORIN rapamycin NDA for microcystic lymphatic malformations, with a PDUFA date of February 28, 2027.

https://biostock.app/symbols/PVLA
October 28, 2026 at 12:42 PM
🚨 $PVLA
On October 28, 2026, Palvella Therapeutics, Inc. issued a press release announcing that the U.S. Food and Drug Administration has accepted for filing and granted Priority Review to the Company’s New Drug Application for QTORINTM 3.9% rapamycin anhydrous gel for the treatment of microcysti...
SEC Filing: PVLA
Click to view the official SEC document.
www.sec.gov
October 28, 2026 at 11:30 AM
FDA accepts #$PVLA QTORIN rapamycin NDA with Priority Review for microcystic lymphatic malformations. Target decision date is February 28, 2027. notreload.xyz/xy/palvella-...
Palvella QTORIN Rapamycin Gets FDA Priority Review
FDA accepts Palvella’s QTORIN rapamycin NDA with Priority Review for microcystic lymphatic malformations. Target decision date is February 28, 2027.
notreload.xyz
October 28, 2026 at 1:34 PM
🔴 #PVLA — Goin Kathleen, Chief Operating Officer
SOLD: 2,043 shares @ $123.62
Total: $253K
Filed Oct 20, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/PVLA

#InsiderTrading #PVLA #StockMarket
FormDelta — Insider Trading Alerts
Goin Kathleen just sold $253K in PVLA. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
October 23, 2026 at 8:09 PM
🔴 #PVLA — Goin Kathleen, Chief Operating Officer
SOLD: 1,663 shares @ $125.16
Total: $208K
Filed Oct 20, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/PVLA

#InsiderTrading #PVLA #StockMarket
FormDelta — Insider Trading Alerts
Goin Kathleen just sold $208K in PVLA. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
October 23, 2026 at 8:09 PM